SAUNDERS BRENT L
SEC CIK 1268854 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLCO | Bausch & Lomb Corp | COB, CEO, Dir | 974.2K | $1.01M | — | 16 | 2024-02-28 | 2026-08-05 |
| SKIN | SkinHealth Systems Inc. | Dir, Executive COB | 5.99M | $405.9K | — | 9 | 2021-09-10 | 2025-06-16 |
| SPRY | ARS Pharmaceuticals, Inc. | Dir | 120.0K | — | $1.71M | 2 | 2025-05-20 | 2025-05-20 |
| CSCO | Cisco | Dir | 24.1K | — | — | 2 | 2021-12-13 | 2022-12-08 |
| BBIO | BridgeBio Pharma, Inc. | Dir | 17.6K | $254.8K | — | 1 | 2021-12-29 | 2021-12-29 |
Most active insiders at BLCO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Munsch Frederick | SVP, CAO, Ctrl | — | $887.7K |
| 2 | VON ESCHENBACH ANDREW C. | Dir | $79.9K | $306.7K |
| 3 | COLLIS STEVEN H | Dir | $267.1K | — |
| 4 | SAUNDERS BRENT L | COB, CEO, Dir | $252.0K | — |
| 5 | Bailey A Robert D | EVP, CLO | $250.4K | — |
| 6 | Ross Thomas W. Sr. | Dir | $79.6K | — |
| 7 | ROBERTSON RUSSEL C | Dir | $78.8K | — |
| 8 | Alfonso Eduardo | Dir | $77.0K | — |
| 9 | Ling Karen | Dir | $71.0K | — |
| 10 | Eldessouky Sam | EVP, CFO | $68.5K | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 16:30 | 2026-08-05 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | COB, CEO, Dir | F - Tax | $16.76 | -4,231 | 974.2K | -0.4% | -$70.9K | |
| 2026-08-07 16:30 | 2026-08-05 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | COB, CEO, Dir | A - Grant | $0.00 | +281.9K | 1.26M | +29% | $0 | |
| 2026-05-26 16:56 | 2026-05-22 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | COB, CEO, Dir | F - Tax | $15.92 | -2,886 | 978.4K | -0.3% | -$45.9K | |
| 2026-03-10 | 2026-03-06 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | A - Grant | $0.00 | +14.7K | 981.3K | +2% | $0 | |
| 2026-03-10 | 2026-03-06 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | P - Purchase | $17.14 | +14.7K | 966.6K | +2% | +$252.0K | |
| M | 2026-03-02 | 2026-02-26+ | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | F - Tax | $18.39 | -46.7K | 951.9K | -5% | -$858.9K |
| 2026-02-27 | 2026-02-25 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | A - Grant | $0.00 | +327.1K | 998.6K | +49% | $0 | |
| 2026-02-25 | 2026-02-23 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | F - Tax | $17.99 | -65.4K | 671.5K | -9% | -$1.18M | |
| 2025-08-07 | 2025-08-05 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | F - Tax | $14.44 | -4,231 | 736.9K | -0.6% | -$61.1K | |
| 2025-06-18 | 2025-06-16 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, COB | A - Grant | — | +73.1K | 5.99M | +1% | — | |
| 2025-05-27 | 2025-05-22 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | P - Purchase | $11.28 | +22.0K | 719.2K | +3% | +$248.2K | |
| 2025-05-27 | 2025-05-22 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | A - Grant | $0.00 | +22.0K | 741.2K | +3% | $0 | |
| D | 2025-05-22 | 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | SAUNDERS BRENT L | Dir | M - OptEx | $1.01 | +120.0K | 120.0K | New | +$121.2K |
| D | 2025-05-22 | 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | SAUNDERS BRENT L | Dir | S - Sale+OE | $14.25 | -120.0K | 0 | -100% | -$1.71M |
| D | 2025-02-28 | 2025-02-26 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | A - Grant | $0.00 | +168.2K | 697.2K | +32% | $0 |
| M | 2024-12-26 | 2024-12-23 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | F - Tax | $17.83 | -98.4K | 529.0K | -16% | -$1.76M |
| 2024-08-13 | 2024-08-12 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, COB | P - Purchase | $1.08 | +40.5K | 5.92M | +0.7% | +$43.7K | |
| 2024-08-07 | 2024-08-05 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | A - Grant | $0.00 | +32.2K | 627.4K | +5% | $0 | |
| 2024-08-07 | 2024-08-05 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | P - Purchase | $15.66 | +32.2K | 595.2K | +6% | +$505.0K | |
| M | 2024-07-10 | 2022-03-31+ | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, COB | F - Tax | $13.06 | -24.7K | 5.80M | -0.4% | -$322.2K |
| 2024-07-10 | 2024-07-08 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, COB | A - Grant | — | +78.5K | 5.88M | +1% | — | |
| D | 2024-03-01 | 2024-02-28 | BLCO | Bausch & Lomb Corp | SAUNDERS BRENT L | CEO, COB, Dir | A - Grant | $0.00 | +187.9K | 562.9K | +50% | $0 |
| 2023-08-17 | 2023-08-16 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, COB | P - Purchase | $6.10 | +59.4K | 5.83M | +1% | +$362.2K | |
| 2023-06-16 | 2023-06-14 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, COB | A - Grant | — | +16.4K | 5.77M | +0.3% | — | |
| 2022-12-12 | 2022-12-08 | CSCO | Cisco | SAUNDERS BRENT L | Dir | A - Grant | $0.00 | +5,001 | 24.1K | +26% | $0 | |
| M | 2022-02-08 | 2022-02-04 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, Executive COB | A - Grant | — | +194.0K | 5.75M | +3% | — |
| 2022-01-31 | 2022-01-27 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, Executive COB | F - Tax | $12.24 | -6,812 | 5.56M | -0.1% | -$83.4K | |
| 2022-01-03 | 2021-12-29 | BBIO | BridgeBio Pharma, Inc. | SAUNDERS BRENT L | Dir | P - Purchase | $14.48 | +17.6K | 17.6K | New | +$254.8K | |
| 2021-12-15 | 2021-12-13 | CSCO | Cisco | Dir | A - Grant | $0.00 | +4,180 | 32.5K | +15% | $0 | ||
| D | 2021-09-14 | 2021-09-10 | SKIN | SkinHealth Systems Inc. | SAUNDERS BRENT L | Dir, Executive COB | A - Grant | $0.00 | +31.0K | 5.56M | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations